Firmani Lori's Form 4 filing
Damora Therapeutics, Inc. (DMRA) · filed Jan 7, 2025
- Accession no.
- 0000950170-25-002813
- Filed
- Jan 7, 2025
- Trade date
- Jan 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.47K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Firmani LoriCIK 0001808248 | Officer (Interim CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Common Stock | MOption exerciseAcquired | +726 | – | – | 726 | Direct | |
| Jan 3, 2025 | Common Stock | SSaleDisposed | −261 | $5.63 | −$1,469.43 | 465 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Common Stock | MOption exerciseDisposed | −726 | $0.00 | $0 | 1,474 | Direct | |
| Jan 3, 2025 | Common Stock | AGrant or awardAcquired | +5,000 | $0.00 | $0 | 5,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.